These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10180854)

  • 21. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cystic fibrosis and its evaluation.
    Wildhagen MF; ten Kate LP; Habbema JD
    Br Med Bull; 1998; 54(4):857-75. PubMed ID: 10367419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
    Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for carriers of cystic fibrosis through primary health care services.
    Watson EK; Mayall E; Chapple J; Dalziel M; Harrington K; Williams C; Williamson R
    BMJ; 1991 Aug; 303(6801):504-7. PubMed ID: 1912861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cascade carrier-testing in cystic fibrosis.
    Roberts T; Schwarz MJ; Kerr-Liddell R; Hinks JL; Super M
    Paediatr Respir Rev; 2003 Dec; 4(4):293-8. PubMed ID: 14629951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
    Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
    Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1996 Mar; 58(3):617-27. PubMed ID: 8644721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
    Bekker H; Modell M; Denniss G; Silver A; Mathew C; Bobrow M; Marteau T
    BMJ; 1993 Jun; 306(6892):1584-6. PubMed ID: 8329922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre.
    Conway SP; Allenby K; Pond MN
    Clin Genet; 1994 Jun; 45(6):308-12. PubMed ID: 7923862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public.
    Watson EK; Williamson R; Chapple J
    Br J Gen Pract; 1991 Jun; 41(347):237-40. PubMed ID: 1931202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for cystic fibrosis carrier state.
    Mennuti MT; Thomson E; Press N
    Obstet Gynecol; 1999 Mar; 93(3):456-61. PubMed ID: 10075000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice.
    Elias S; Annas GJ; Simpson JL
    Am J Obstet Gynecol; 1991 Apr; 164(4):1077-83. PubMed ID: 2014829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrier screening in the community.
    Brock DJ
    J Inherit Metab Dis; 1995; 18(4):525-32. PubMed ID: 7494411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using operational research modelling to improve the provision of health services: the case of DNA technology.
    Beech R
    Int J Epidemiol; 1995; 24 Suppl 1():S90-5. PubMed ID: 7558560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.